The Department of Defense offers the OCRP Investigator-Initiated Research Award to fund impactful studies that advance ovarian cancer research and patient care. Projects can encompass various research phases and must be grounded in relevant preliminary data. Research ideas can stem from laboratory findings, population studies, clinical insights, or anecdotal evidence. This grant aims to drive innovation in the field of ovarian cancer research. Closing date for applications is August 27, 2014.
Opportunity ID: 253890
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-14-OCRP-IIRA |
Funding Opportunity Title: | DoD Ovarian Cancer Investigator-Initiated Research Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 4 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 15, 2014 |
Last Updated Date: | – |
Original Closing Date for Applications: | Aug 27, 2014 |
Current Closing Date for Applications: | Aug 27, 2014 |
Archive Date: | Sep 26, 2014 |
Estimated Total Program Funding: | $2,880,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: | The OCRP Investigator-Initiated Research Award is intended to support studies that will significantly impact ovarian cancer research and/or patient care. Research projects may focus on any phase of research from basic laboratory research through translational research. The rationale for a research idea may be derived from a laboratory discovery, population-based studies, a clinicians first-hand knowledge of patients, or anecdotal data. Applications must include preliminary data that are relevant to ovarian cancer and support the proposed research project. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
301-682-5507; help@eBRAP.org
Email:help@eBRAP.org |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 253890 Full Announcement-1 -> w81xwh-14-ocrp-iira.pdf
Packages
Agency Contact Information: | 301-682-5507; help@eBRAP.org Email: help@eBRAP.org |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
12.420 | PKG00195285 | Apr 15, 2014 | Aug 27, 2014 | View |
Package 1
Mandatory forms
253890 RR_SF424_2_0-2.0.pdf
253890 RR_Budget_1_3-1.3.pdf
253890 RR_KeyPersonExpanded_2_0-2.0.pdf
253890 PerformanceSite_2_0-2.0.pdf
Optional forms
253890 RR_SubawardBudget30_1_3-1.3.pdf